News & Updates

Show Multimedia Only
Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

17 Aug 2026 byNatalia Reoutova

A retrospective cohort study conducted in Hong Kong among adults with co-existing asthma and diabetes mellitus (DM) has found a lower risk of asthma exacerbation with glucagon-like peptide-1 receptor agonist (GLP-1 RA) vs dipeptidyl peptidase-4 inhibitor (DPP-4i) treatment.

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

17 Aug 2026
Nutritional anaemia raises mortality, readmission risks in patients with AECOPD

Nutritional anaemia raises mortality, readmission risks in patients with AECOPD

13 Aug 2026 byStephen Padilla

Anaemia affects nearly one in five patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and contributes to increased postdischarge mortality and readmission, a study has found. Its most common subtype is nutritional anaemia, followed by anaemia of chronic disease (ACD).

Nutritional anaemia raises mortality, readmission risks in patients with AECOPD

13 Aug 2026